Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Texas, United States
Countries of investment
  • USA
Investment stages
  • Series A
  • Series B
Industries
  • Media
  • Web3
  • Blockchain
  • Biotechnology
  • Gaming
  • Cryptocurrency
  • AdTech
  • Legal Services
About
Colossal Biosciences focuses on advancing de-extinction efforts by utilizing gene editing technology to resurrect the Woolly Mammoth, aiming to restore lost ecosystems and promote biodiversity.
Min check size
$10M
Max check size
$30M
Fund size
NPS

Investment Thesis

They Focus on advancing cuttingedge biotechnology and deextinction projects, aiming to bring back extinct species and restore ecosystems through breakthrough genetic engineering.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Backed by over a decade of experience, the fund manager has developed a robust portfolio across technology, healthcare, and consumer sectors. Operating primarily in North America and Europe, they have successfully closed more than 50 deals, showcasing a strong focus on early to growth-stage investments. Their strategic approach is data-driven, emphasizing thematic trends that align with emerging market demands. Notable exits include several high-profile IPOs, underscoring a proven track record for generating substantial returns.

Colossal Biosciences Contacts Information

Primary contact

Team

Amanda Bastawros

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp